Clinical trial
Evaluating the Specific Role of Endogenous Opioids as the Mechanism Underlying tAN-based Analgesia in Healthy Individuals
NCT05490134 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Specific Role of Endogenous Opioids as the Mechanism Underlying tAN-based Analgesia in Healthy Individuals
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 22, 2023
- Completion date
- October 1, 2027
- Enrollment
- 136 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia